Overview
The purpose of this study is to determine the safety of Fycompa for injection after administration in participants with epilepsy (partial-onset seizures [including secondarily generalized seizures]) (age 4 years or older) or primary generalized tonic-clonic seizures (age 12 years or older).
Eligibility
Inclusion Criteria:
- Participants with epilepsy who received the Fycompa for injection for the first time will be included.
Exclusion Criteria:
- The exclusion criteria will not be specified in particular because this survey will be conducted in daily clinical practice.